Historical / government
NASA-supported LED development and medical research history
What this record reports
NASA’s retrospective account traces space-oriented LED plant-growth work and later NASA SBIR-supported collaborations investigating medical LED applications.
Important limits
- A retrospective institutional history is not clinical efficacy evidence.
- The account does not support the claim that NASA invented red-light therapy or proved consumer panels effective.
NASA Research Illuminates Medical Uses of Light
Mixed evidence
NASA NTRS conference record on LED biostimulation
What this record reports
The conference record describes NASA-contract work using LED arrays in laboratory and early medical investigations and identifies 680, 730 and 880 nm systems.
Important limits
- This is a conference paper record, not a systematic review or large confirmatory trial.
- The work combines different experimental systems and cannot establish one general treatment effect.
The Use of NASA Light-Emitting Diode Near-Infrared Technology for Biostimulation
Mixed evidence
Whelan et al. wound-healing report (2001)
Population: Cell cultures, rodent wound models and early human observations in distinct settings
What this record reports
The paper reported results across cell-culture experiments, ischaemic and diabetic rat wound models, and early human observations, including oral-mucositis pain work.
Important limits
- The publication mixes a review with heterogeneous laboratory, animal and human data.
- Its early human observations were not a large, generalisable consumer-device trial.
- Different wavelengths, doses and settings prevent a single broad efficacy conclusion.
Effect of NASA light-emitting diode irradiation on wound healing
Controlled human
Whelan et al. paediatric oral-mucositis study (2002)
Population: 32 consecutive paediatric bone-marrow transplant patients
What this record reports
The study compared daily 670 nm LED treatment on one side of the mouth with sham treatment on the other and also used historical incidence estimates. It reported some favourable incidence and pain observations.
Important limits
- The sample was small and included a historical comparison.
- The abstract reported no significant left-versus-right difference in oral-mucositis index or pain scores.
- The authors concluded that further study was required.
NASA light-emitting diodes for the prevention of oral mucositis in pediatric bone marrow transplant patients
Randomised controlled human
Hodgson et al. transplant oral-mucositis trial (2012)
Population: 80 adult and paediatric haematopoietic stem-cell transplant patients
What this record reports
This placebo-controlled trial tested extra-oral 670 ± 10 nm LED treatment. It found a statistically significant pain difference for one specified comparison at day 14; most other improvements were not statistically significant.
Important limits
- The result was specific to transplant-associated oral mucositis and a defined protocol.
- Most assessed between-group differences were not statistically significant.
- It does not validate unspecified consumer panel protocols or unrelated health claims.
Amelioration of oral mucositis pain by NASA near-infrared light-emitting diodes in bone marrow transplant patients
Terminology consensus
Photobiomodulation terminology paper (2015)
What this record reports
The authors argued for “photobiomodulation therapy” as a more accurate term than legacy labels such as low-level laser therapy.
Important limits
- This is a terminology paper, not an evaluation of efficacy for a particular condition or device.
Low-level light/laser therapy versus photobiomodulation therapy
Systematic review / meta-analysis
LED oral-mucositis systematic review and GRADE analysis (2025)
Population: Five studies with 256 cancer patients
What this record reports
Four included studies reported improvements in oral-mucositis severity or pain, but heterogeneity prevented meta-analysis and the review rated the certainty of evidence as low.
Important limits
- Only five studies were included and their data were too heterogeneous for meta-analysis.
- Risk of bias was moderate and GRADE certainty was low.
- The conclusions concern cancer-therapy-associated oral mucositis, not broad consumer wellness outcomes.
LED-based low-level light therapy for oral mucositis in cancer patients: a systematic review and GRADE analysis
Narrative / clinical review
Photobiomodulation mechanisms review (2017)
What this record reports
The review describes proposed red- and near-infrared-light pathways involving chromophores, signalling changes and a biphasic dose response.
Important limits
- A mechanistic review does not establish clinical benefit for every indication.
- Proposed pathways and preclinical findings should not be presented as settled treatment outcomes.
Mechanisms and applications of the anti-inflammatory effects of photobiomodulation
Narrative / clinical review
Clinical photobiomodulation overview (2024)
What this record reports
This clinical review describes PBM as non-invasive phototherapy commonly using red (620–700 nm) and near-infrared (700–1440 nm) light and stresses that fluence, treatment duration and output power affect treatment.
Important limits
- The spectral ranges are broad field definitions, not a claim that every wavelength or protocol is equivalent.
- The review does not validate every consumer device or marketing claim.
Photobiomodulation CME part I: Overview and mechanism of action
Systematic review
PBM radiometry and parameter-reporting review (2016)
What this record reports
This review of 74 PBM papers found frequent omissions and measurement problems. It identifies wavelength, irradiance, exposure time, beam area at the target, spatial distribution, pulse parameters and anatomical location as important for repeatability.
Important limits
- The review evaluates reporting and radiometry, not whether panels or masks are clinically superior.
- It sampled papers from a defined 2014–2015 search period.
- One author was affiliated with a photomedicine-device company.
The dark art of light measurement: accurate radiometry for low-level light therapy
Narrative / clinical review
PBM parameter-complexity review (2018)
What this record reports
The review describes how wavelength, energy, irradiance, pulse mode, treatment duration and repetition interact, and reports substantial variability across effective and ineffective studies.
Important limits
- The synthesis spans laboratory and clinical contexts and does not produce one transferable consumer protocol.
- Its parameter ranges should not be converted into individual treatment instructions.
Review of light parameters and photobiomodulation efficacy: dive into complexity
Systematic review
LED dermatology randomised-trial review (2018)
Population: 31 randomised controlled trials across several dermatological uses
What this record reports
The review found a varied clinical literature across dermatological applications and devices. For skin rejuvenation it described heterogeneous wavelengths, irradiances, radiant exposures and schedules rather than one settled protocol.
Important limits
- The search ended in September 2017 and the review combined different skin conditions and outcomes.
- Some included trials were small, lacked blinding or sham control, or omitted treatment parameters.
- The review does not establish equivalence between a wearable mask and a panel.
Light-emitting diodes in dermatology: A systematic review of randomized controlled trials
Systematic review / meta-analysis
LED skin-therapy systematic review and meta-analysis (2023)
Population: 31 studies across several skin applications; six studies and 268 participants in the skin-rejuvenation analysis
What this record reports
The meta-analysis reported a pooled favourable effect for skin-rejuvenation outcomes, but combined heterogeneous interventions and outcome scales.
Important limits
- The authors identified possible publication bias in the skin-rejuvenation literature.
- Intervention conditions varied and follow-up was generally short.
- The pooled result cannot establish a best wavelength, dose, schedule or consumer mask.
Utilization of light-emitting diodes for skin therapy: Systematic review and meta-analysis
Systematic review
Visible-LED dermatology methodology review (2025)
Population: 27 visible-LED dermatology studies, including five wrinkle studies
What this record reports
The review found wide variation and incomplete reporting of treatment parameters, heterogeneous outcomes, limited blinding and no independent verification of stated fluence in the studies it assessed.
Important limits
- The review covers visible LED studies and should not be treated as a complete review of near-infrared PBM.
- It assesses research reporting and methodology rather than estimating one pooled facial-skin effect.
Methodological issues in visible LED therapy dermatological research and reporting
Randomised controlled human
Omnilux Revive randomised half-face study (2005)
Population: 23 volunteers
What this record reports
Subjective and blinded photographic assessments suggested visible change, while objective hydration and elasticity measures did not show significant improvement.
Important limits
- Small sample and short intervention.
- The untreated side was not a light-emitting sham.
- This professional lamp is not the current Omnilux Contour Face mask.
A single-blinded randomised controlled study to determine the efficacy of Omnilux Revive facial treatment in skin rejuvenation
Randomised controlled human
Facial LED skin-rejuvenation trial (2007)
Population: 76 people with facial wrinkles allocated across three active settings and a sham-light group
What this record reports
The study applied specific 633 nm, 830 nm or combined LED settings to one side of the face twice weekly for four weeks and reported improvements from baseline in active groups across several measured outcomes.
Important limits
- It tested defined devices and treatment settings, not panels versus wearable masks.
- A result from these settings cannot be inferred from wavelength alone.
- The abstract foregrounds changes from baseline; it does not establish that every reported endpoint differed from sham.
A prospective, randomized, placebo-controlled, double-blinded, and split-face clinical study on LED phototherapy for skin rejuvenation
Randomised controlled human
Home-use LED mask crow’s-feet trial (2025)
Population: 60 adults of Asian descent aged 30–65 with specified crow’s-feet grades
What this record reports
This multicentre double-blind trial compared one 630 nm and 850 nm home-mask protocol with a visually matched lower-output sham for 16 weeks and reported between-group differences in crow’s-feet assessments from week eight.
Important limits
- It studied one mask, one protocol and one temporary facial-appearance outcome.
- The population and eligibility criteria limit generalisation.
- The result does not validate other masks, panels, wavelengths or treatment aims.
- The PubMed abstract contains inconsistent irradiance-unit rendering; PLT does not reuse it as a shopping specification.
Clinical study to evaluate the efficacy and safety of home-used LED and IRED mask for crow's feet: A multi-center, randomized, double-blind, sham-controlled study
Randomised controlled human
Red versus broad-spectrum white LED wrinkle trial (2017)
Population: 52 adult women
What this record reports
Both active-light groups improved on one replica measure, but the study found no between-group difference and blinded dermatologists did not detect significant change.
Important limits
- No untreated or sham comparator, so the study cannot estimate improvement against no light treatment.
- Different outcome methods gave different conclusions.
The efficacy and safety of 660 nm and 411 to 777 nm light-emitting devices for treating wrinkles
Controlled human
Home-use LED split-face photoageing study (2020)
Population: 24 people with photoaged facial skin
What this record reports
This small home-use split-face study reported treatment-side improvements in elasticity and texture after a defined 637/854 nm protocol.
Important limits
- Small sample and eight-week intervention.
- An untreated side does not control for expectation or visible treatment assignment as well as a credible sham.
- The result does not establish equivalence with a current commercial mask.
Efficacy of home-use light-emitting diode device at 637 and 854-nm for facial rejuvenation: A split-face pilot study
Randomised controlled human
Red versus amber periocular-wrinkle split-face trial (2023)
Population: 137 women aged 40–65 with Fitzpatrick phototypes II–IV
What this record reports
Wrinkle volume improved from baseline on both red- and amber-treated sides, while hydration and viscoelasticity did not.
Important limits
- No untreated or sham control, so change over time cannot be attributed exclusively to PBM.
- This was a wavelength comparison, not a mask comparison.
Photobiomodulation reduces periocular wrinkle volume by 30%: A randomized controlled trial
Randomised controlled human
Facial PBM frequency sham-controlled mask trial (2025)
Population: 95 women aged 45–60
What this record reports
The trial produced mixed findings: its clinical wrinkle scale did not differ between groups, while selected image-analysis measures and satisfaction favoured active treatment.
Important limits
- Short four-week intervention.
- Different outcome measures did not agree uniformly.
- The paper does not establish one preferred treatment frequency for consumers.
Role of photobiomodulation application frequency in facial rejuvenation: randomized, sham-controlled, double-blind, clinical trial
Terminology consensus
CIE definitions of irradiance and radiant exposure
What this record reports
CIE defines irradiance as incident radiant flux per unit area at a surface and radiant exposure as incident radiant energy per unit area. Radiant exposure is the time integral of irradiance; PLT uses these surface quantities for its worked examples.
Important limits
- Physical definitions do not identify a biologically effective or clinically appropriate exposure.
- The CIE base units are W/m² and J/m²; consumer PBM material commonly uses mW/cm² and J/cm².
International Lighting Vocabulary: irradiance (17-21-053) · International Lighting Vocabulary: radiant exposure (17-21-071)
Methodology guidance
Photomedicine dose and beam reporting guidance (2011)
What this record reports
The guidance calls for reporting wavelength, output power, irradiance, beam area, exposure time, radiant exposure and pulse parameters, with fuller reporting of application technique, beam profile and spectral width.
Important limits
- This is reporting guidance, not a clinical trial or validation of a consumer device.
- Both authors listed commercial photomedicine affiliations.
How to report low-level laser therapy (LLLT)/photomedicine dose and beam parameters in clinical and laboratory studies
Narrative / clinical review
PBM biphasic dose-response review (2011)
What this record reports
The review describes non-linear and dose-rate-dependent responses in PBM research, showing why equal calculated radiant exposure does not necessarily imply equal biological response.
Important limits
- The evidence reviewed was predominantly laboratory and animal work rather than broad confirmatory human evidence.
- The paper does not define a universal optimum or consumer dose range.
- One author had a commercial photomedicine affiliation.
Biphasic dose response in low level light therapy—an update
Narrative / clinical review
Optical properties of biological tissues review (2013)
What this record reports
The review describes wavelength-dependent tissue absorption and scattering and variation with tissue chromophores and structure.
Important limits
- Generic tissue-optics models do not determine the exposure at a particular person’s biological target.
- Optical penetration does not itself establish a beneficial biological or clinical effect.
Optical properties of biological tissues: a review
Prospective human · no control
Early Omnilux-system facial skin-rejuvenation study (2005)
Population: 31 subjects with facial rhytids
What this record reports
A study associated with an Omnilux LED system evaluated repeated 633 nm and 830 nm treatment for facial rhytids and reported changes in clinical appearance measures.
Important limits
- The PubMed record concerns an earlier Omnilux system, not a verified current Contour Face hardware match.
- The study does not establish that every current mask using 633 nm and 830 nm produces the same result.
- The evidence is relevant to a platform history and protocol, not an independent current-product ranking.
A study to determine the efficacy of combination LED light therapy (633 nm and 830 nm) in facial skin rejuvenation
Prospective human · no control
CurrentBody Skin Series 2 manufacturer-presented 56-day study (2024)
Population: 35 participants in a manufacturer-presented 56-day study
What this record reports
The full SGS report documents multiple within-participant changes during exact-device use, but without a control group it cannot separate treatment effects from time, expectation, measurement variability or other changes.
Important limits
- The full report is manufacturer-hosted and is not a peer-reviewed publication.
- The study has no control group and tests many outcomes against baseline.
- The study does not establish superiority over other masks or panels.
- Reported outcomes should not be generalized beyond the studied device, regimen and endpoints.
CurrentBody Skin Series 2 clinical study summary · Series 2 SGS clinical assessment report QDCPCH24000497-02_EN-V2
Prospective human · no control
TheraFace Mask Glo manufacturer-presented clinical study (2025)
Population: 115 enrolled; manufacturer reports 104 completed the 12-week study
What this record reports
The registry verifies the exact device, sponsor and single-group protocol, while outcome claims remain available only through the manufacturer summary. The combined light-and-vibration regimen cannot isolate red/NIR effects.
Important limits
- The public outcome source is a manufacturer-authored summary; no full results report or peer-reviewed publication was identified.
- There was no control group, and the protocol combined several light modes with vibration.
- The result does not establish that the Glo mask is superior to other masks or that its findings transfer to other devices.
- The source does not justify treating “clinically proven” as a universal quality or efficacy label.
TheraFace Mask Glo clinical study summary · Clinical study to evaluate the efficacy of a light therapy facial mask in improving skin health (NCT07054710)